2024-05-09T08:47:55-05:00 2023-06-30 990 2022-07-01 232020897 MONELL CHEMICAL SENSES CENTER % David E Gabl MONE 2675194700 3500 Market Street Philadelphia PA 191043308 DAVID E GABL Controller 2675194700 2024-05-09 DAVID GABL XXX-XX-XXXX false 1 AAL2 IAL1 2022 2023-04-26 12:10:37Z NANCEY RAWSON PHD 3500 Market Street Philadelphia PA 191043308 26549801 false X www.Monell.org X 1976 PA To advance scientific understanding of the mechanisms and functions of the chemical senses to benefit human health and wellbeing 11 10 158 31 188369 34554427 18044183 0 214864 418528 408399 302934 35177690 18765645 0 0 9608019 10736916 0 1006747 6900831 7436261 16508850 18173177 18668840 592468 40304892 41687371 5206641 5505991 35098251 36181380 To advance knowledge of the mechanisms and functions of the chemical senses: taste, smell and chemosensory irritation. false false 13828349 The Monell Chemical Senses Center is a non-profit independent scientific institute dedicated to interdisciplinary basic research on the senses of taste, smell and chemosensory irritation. In addition to increasing fundamental knowledge about the chemical senses, basic research at Monell relates to significant public health and quality of life issues, including obesity, diabetes, hypertension, pediatric health, occupational safety, environmental pollution, and homeland security. Our appreciation of many of lifes pleasures, such as the evocative realms of scent and flavor, also is enhanced through discoveries from Monell. Monells science connects us intimately to the world around us, helping to improve the human experience. 13828349 true true false true false false false false false true true false false false false true true false false false false false false false false false false false false true false false false false false false false false true false false false false false false false false true X 71 0 true 158 true true true false false false false false false false false X 11 10 false false false false false false false true true false false true true true true true true true true false PA X DANIELLE COYNE 2675194700 3500 Market Street Philadelphia PA 191043308 NANCY E RAWSON PHD MSC FCPP Acting Direct Pres 40.00 X X 221701 0 28057 JULIA MENNELLA PHD Scientist Member 40.00 X 213371 0 24377 ROBERT MARGOLSKEE MD PHD Scientist Member 40.00 X 210351 0 18513 EDWARD L O'NEILL CFOTreasurerActg Sec 40.00 X 194182 0 37869 MAUREEN O'LEARY PHD Director Tech Transf 40.00 X 185218 0 11941 PAMELA DALTON PHD Scientist Member 40.00 X 173658 0 23868 DANIELLE REED PHD Assoc DirMemberScien 40.00 X 169510 0 40239 DAVID MACNAIR PHD Chairman of the Board 1.000 X 0 0 0 RICHARD L BERKMAN ESQ Vice Chairman of Board 3.000 X 0 0 0 TODD ABRAHAM PHD MBA ChrmnIntrnl Adv Counc 1.000 X 0 0 0 SUSAN S DE MARS JD Board Member 1.000 X 0 0 0 KEVIN FOSKETT PHD Board Member 1.000 X 0 0 0 PAUL HERZAN Board Member 1.000 X 0 0 0 STEPHEN MANHEIMER Board Member 1.000 X 0 0 0 MAURIZIO MORELLO ESQ Board Member 1.000 X 0 0 0 AMBROSE K MONELL Board Member 1.000 X 0 0 0 ANGELA NWANERI Board Member 1.000 X 0 0 0 JUDITH WELLINGTON PHD Board Member 1.000 X 0 0 0 1367991 184864 24 false true false Children's Hosp of Phila PO Box 8500 Philadelphia PA 19178 SubcontrctScientific Res 517029 Bruker PO Box 536516 Pittsburgh PA 152535907 Research Equipment 322020 Sable Systems Intl 3840 N Commerce St North Las Vegas NV 89032 Research Equipment 200000 Northwestern University 633 Clark St Ste G547 Evanston IL 60208 SubcontrctScientific Res 178398 Newport Corporation 27631 Network Place Chicago IL 606731276 Research Equipment 165883 10 6885167 11159016 35204 18044183 336804 336804 11311 11311 753987 462364 291623 291623 188369 103254 7403516 7321373 419 82143 -419 81724 81723 0 18765645 188369 533092 X 513743 459045 54698 8040698 5710622 1866721 463355 436818 383663 29069 24086 1141517 1052041 23617 65859 604140 426100 142804 35236 90737 63588 27149 81571 81571 900 900 37452 37452 354606 115833 238773 104497 61479 23628 19390 115916 69747 46169 1334750 1230639 82755 21356 272231 214258 190 57783 131462 103624 27838 85338 78052 5932 1354 1164424 1072296 73230 18898 279439 257643 17325 4471 Research Supplies 1056808 1056808 Research Services & Expenses 2030620 1755057 275563 Printing & Publications 18021 15243 1290 1488 Uncoll.Pledges & Grants 277489 277489 18173177 13828349 3338081 1006747 6847 6563 7457896 7605705 13883385 9326788 211378 94821 51496 168686 38612343 26317354 12680176 12294989 6001859 12150179 11855 39640 40304892 41687371 855949 807788 2262494 2693475 2088198 2004728 5206641 5505991 X 31933418 33063633 3164833 3117747 35098251 36181380 40304892 41687371 X 592468 490661 X X false true X true true true X 13632861 12255047 13665235 34554427 18044183 92151753 13632861 12255047 13665235 34554427 18044183 92151753 29410344 62741409 555743 714965 836377 906968 1102101 4116154 96267907 0.65174 0.67421 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false false false false false false false true 900 false false 900 false false P2-B, Ln 1 A 20% portion of the membership fee paid to the Association of P2-B, Ln 1 Independent Research Institute, (AIRI), represents lobbying P2-B, Ln 1 activities. The cost of this organization was $900 for the June 30, P2-B, Ln 1 2023 year end. false false false false false false false 16931568 553588 127580 147990 17464746 1504495 16309805 -717078 165654 16931568 1422448 50505 215260 183718 1504495 1494773 50200 24942 147467 1422448 1615891 50200 56570 227888 1494773 0.84682 0.15318 false false 450406 450406 25794902 16505418 9289484 12160148 9612039 2548109 206887 199897 6990 12294989 Interest Receivable 39640 39640 X 19681217 490661 462363 953024 18728193 37452 37452 18765645 18598088 462363 462363 18135725 37452 37452 18173177 P5, Ln 4 The endowment fund was established by restricted gifts from donors. P5, Ln 4 Endowment funds subject to FASB ASC 958 include funds established by donors P5, Ln 4 to provide annual funding for specific activities and general operations. P5, Ln 4 Monell has adopted an investment policy for endowment assets that provides P5, Ln 4 primarily for the preservation of capital, real growth after inflation and P5, Ln 4 capital appreciation. The income on the endowment assets is used in P5, Ln 4 accordance with donor stipulations. No formal spending policy has been P5, Ln 4 adopted. One of Monell's endowments is the Martin Meyerson Lectureship P5, Ln 4 Fund. The investment income earned on this endowment is restricted for P5, Ln 4 lectureships. Investment income on all other endowments is unrestricted, P5, Ln 4 income without donor restrictions on the accompanying statements of P5, Ln 4 activities. P10, Ln 2 Monell has been granted an exempt status from federal, state and local P10, Ln 2 income taxes under each jurisdiction's respective tax law; therefore, no P10, Ln 2 provision for income taxes has been included in the accompanying financial X false false false false false false false false false NANCY E RAWSON PHD MSC FCPP Acting Direct Pres 219415 2286 13531 14526 249758 JULIA MENNELLA PHD Scientist Member 211085 2286 12852 11525 237748 ROBERT MARGOLSKEE MD PHD Scientist Member 208065 2286 14907 3606 228864 EDWARD L O'NEILL CFOTreasurerActg Sec 191896 2286 11984 25885 232051 MAUREEN O'LEARY PHD Director Tech Transf 184444 774 11085 856 197159 PAMELA DALTON PHD Scientist Member 171372 2286 10577 13291 197526 DANIELLE REED PHD Assoc DirMemberScien 168322 1188 10771 29468 209749 DAVID MACNAIR PHD Chairman of the Board RICHARD L BERKMAN ESQ Vice Chairman of Board TODD ABRAHAM PHD MBA ChrmnIntrnl Adv Counc SUSAN S DE MARS JD Board Member KEVIN FOSKETT PHD Board Member PAUL HERZAN Board Member STEPHEN MANHEIMER Board Member MAURIZIO MORELLO ESQ Board Member AMBROSE K MONELL Board Member ANGELA NWANERI Board Member JUDITH WELLINGTON PHD Board Member X 1 35204 Avg Shr Price false true true P1, Ln 32b For non-cash gifts that are relating to publicly traded securities, Monell P1, Ln 32b uses an investment brokerage firm to sell the securities. Part VI Line 11b The 990 form is reviewed by the independent auditors, as well as all Board Part VI Line 11b Members and Finance Committee of the Board prior to filing. Part VI Line 12c We require the Board Members and senior personnel to complete a Conflict of Part VI Line 12c Interest Disclosure Form on an annual basis and update as required. Part VI Line 19 We supply these documents upon valid request. Part I, Line 5 The number of W-2 Forms is based on the number of social security numbers. Part I, Line 5 Some employees may have received more than one W-2 form due to change in Part I, Line 5 employment status, address, etc. Therefore, this number may differ from the Part I, Line 5 W-3 transmittal form. Part V, Line 2a The number of W-2 Forms is based on the number of social security numbers. Part V, Line 2a Some employees may have received more than one W-2 form due to change in Part V, Line 2a employment status, address, etc. Therefore, this number may differ from the Part V, Line 2a W-3 transmittal form. Part VI, Line 15 The Board of Directors determine compensation for the President / Director Part VI, Line 15 of the Center and decide on the general annual increase rate of all Part VI, Line 15 employees. The President / Director of the Center determines the salary Part VI, Line 15 for senior personnel based on performance. Part IX, Line 5 The compensation of officers is prepared on a fiscal year basis using Part IX, Line 5 Monell's June 30, 2023 audited financial statements. This amount will Part IX, Line 5 differ from officers compensation amounts shown on Form 990, Part VII and Part IX, Line 5 Schedule J, which are based on calendar year 2022 W-2 information. Part XI, Line 5 This represents net unrealized loss on investments that are accounted for Part XI, Line 5 on Monell's books but are excluded for tax purposes until recognized.